Some explanation for CXS's relative stability is that the Health/Pharma sector is only one of 3 sectors currently with uptrending charts. While I realise CXS is only a late stage trials biotech outfit their studies continue to produce positive results. Morever, directors holdings are significant, on a percentage basis more than most listed stocks. Recent break out from a pennant. Importantly, as a consequence of the recent rally weekly chart indicators particularly have further ticked up.
CXS Price at posting:
0.0¢ Sentiment: Hold Disclosure: Held
